User profiles for M. Breeden

Melissa L. Breeden

Research Scientist, NOAA PSL
Verified email at noaa.gov
Cited by 132

[HTML][HTML] Cardiomyopathy: an overview

JAY Brieler, MA Breeden, J Tucker - American family physician, 2017 - aafp.org
The definition and classification of cardiomyopathy have evolved considerably in recent
years. Cardiomyopathy can be separated into primary (genetic, mixed, or acquired) and …

Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse

S Werner, M Breeden, G Hübner… - Journal of Investigative …, 1994 - Elsevier
We have recently demonstrated induction of expression of several members of the fibroblast
growth factor family during wound healing, particularly for keratinocyte growth factor, which …

Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors

…, G Garcia-Manero, F Giles, M Breeden… - Blood, The Journal …, 2007 - ashpublications.org
Dasatinib and nilotinib are potent tyrosine kinase inhibitors (TKIs) with activity against many
imatinib-resistant chronic myeloid leukemia (CML) clones with BCR-ABL kinase domain (KD…

PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse

RL Brown, MP Breeden, DG Greenhalgh - Journal of Surgical Research, 1994 - Elsevier
Impaired wound healing results in significant morbidity for the surgical patient. The
genetically diabetic (C57BL/KsJ-db/db) mouse is obese, hyperglycemic, insulin-resistant, and …

Kinase domain point mutations in Philadelphia chromosome‐positive acute lymphoblastic leukemia emerge after therapy with BCR‐ABL kinase inhibitors

…, CC Yin, S O'Brien, JE Cortes, E Jabbour, M Breeden… - Cancer, 2008 - Wiley Online Library
BACKGROUND. BCR‐ABL kinase domain (KD) mutations are detected in approximately 45%
of patients with imatinib‐resistant chronic myeloid leukemia. Patterns of KD mutations in …

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy

…, H Kantarjian, D Jones, M Breeden… - Blood, The Journal …, 2008 - ashpublications.org
Chronic myeloid leukemia (CML) with T315I mutation has been reported to have poor
prognosis. We analyzed 27 patients with T315I, including 20 who developed T315I after imatinib …

[PDF][PDF] Aptamers: prospects in therapeutics and biomedicine

AC Yan, KM Bell, MM Breeden, AD Ellington - Front Biosci, 2005 - article.imrpress.com
… As an example, oncostatin M (OSM) is a cytokine strongly implicated in rheumatoid arthritis
and may have roles in mediating cell growth and differentiation. Recent interest in OSM has …

Successful treatment of prolonged severe acute respiratory syndrome coronavirus 2 infection in patients with immunodeficiency with extended nirmatrelvir/ritonavir …

M Breeden, SL Aitken, JH Baang… - Open Forum …, 2023 - academic.oup.com
Immunocompromised patients with B-cell deficiencies are at risk for prolonged symptomatic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We describe 4 …

PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice.

S Albertson, RP Hummel 3rd, M Breeden… - Surgery, 1993 - europepmc.org
Background Growth factors have been shown to improve healing in impaired models but
not after malnutrition. The effects of growth factors on altered tissue repair caused by …

[HTML][HTML] The February 2021 cold air outbreak in the United States: A subseasonal forecast of opportunity

…, M Newman, A Hoell, ML Breeden… - Bulletin of the …, 2022 - journals.ametsoc.org
The sources of predictability for the February 2021 cold air outbreak (CAO) over the central
United States, which led to power grid failures and water delivery shortages in Texas, are …